Certara Blog Certara Expands the Simcyp Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

RADNOR, PA - April 1st, 2025 - Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, has released a new version of the Simcyp Simulator for physiologically-based pharmacokinetic (PBPK) modeling.The post Certara Expands the Simcyp Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities appeared first on Certara.